PTPN13 and metabolic dysfunction-associated steatohepatitis: The levels of FAP-1 (figure 7b) the immediate target of miR200c was down regulated by 2.6 fold in the chronic HCV infected liver with fibrosis but was not affected in HCV livers with no fibrosis (1.3 fold) or in NASH (1.0 fold).